NCT00295750 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 201
- group Id
- BG003
- value
- 610
- units
- Participants
- groups
- description
- Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 160 mg SC (by injection under the skin) given every 28 days.
- id
- BG000
- title
- Degarelix 240/160 mg
- description
- Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 80 mg SC (by injection under the skin) given every 28 days.
- id
- BG001
- title
- Degarelix 240/80 mg
- description
- Lupron Depot 7.5 mg IM (in the muscle) every 28 days starting at day 0.
- id
- BG002
- title
- Leuprolide 7.5 mg
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 118
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 164
- group Id
- BG002
- value
- 163
- group Id
- BG003
- value
- 492
- title
- >=65 years
- description
- Intent-to-treat (ITT) population.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 50
- spread
- 8.47
- upper Limit
- 88
- value
- 72
- group Id
- BG001
- lower Limit
- 51
- spread
- 8.12
- upper Limit
- 89
- value
- 72
- group Id
- BG002
- lower Limit
- 52
- spread
- 8.77
- upper Limit
- 98
- value
- 74
- group Id
- BG003
- lower Limit
- 50
- spread
- 8.45
- upper Limit
- 98
- value
- 73
- description
- ITT population.
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 201
- group Id
- BG003
- value
- 610
- title
- Male
- description
- ITT population.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 59
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 38
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 168
- group Id
- BG001
- value
- 171
- group Id
- BG002
- value
- 172
- group Id
- BG003
- value
- 511
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- description
- ITT population
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 87
- group Id
- BG002
- value
- 86
- group Id
- BG003
- value
- 257
- title
- North America
- categories
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 120
- group Id
- BG002
- value
- 115
- group Id
- BG003
- value
- 353
- title
- Europe
- description
- ITT population
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 78
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 178
- group Id
- BG001
- value
- 177
- group Id
- BG002
- value
- 177
- group Id
- BG003
- value
- 532
- title
- No
- description
- ITT population. Curative intent refers to radical prostatectomy or radiotherapy.
- param Type
- NUMBER
- title
- Curative Intent
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 65
- title
- 2-4
- categories
- measurements
- group Id
- BG000
- value
- 67
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 198
- title
- 5-6
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 181
- title
- 7
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 163
- title
- 8-10
- description
- ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.
- param Type
- NUMBER
- title
- Gleason Score
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 191
- title
- Localized
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 178
- title
- Locally advanced
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 125
- title
- Metastatic
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 116
- title
- Not classifiable
- description
- ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis
- param Type
- NUMBER
- title
- Stage of Prostate Cancer
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.70
- value
- 26.6
- group Id
- BG001
- spread
- 4.21
- value
- 26.7
- group Id
- BG002
- spread
- 3.86
- value
- 26.9
- group Id
- BG003
- spread
- 3.93
- value
- 26.8
- description
- ITT population
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index
- unit Of Measure
- kilogram per square meter
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 8.2
- upper Limit
- 68
- value
- 19.9
- group Id
- BG001
- lower Limit
- 9.4
- upper Limit
- 46
- value
- 19.8
- group Id
- BG002
- lower Limit
- 8.7
- upper Limit
- 57
- value
- 19.0
- group Id
- BG003
- lower Limit
- 8.7
- upper Limit
- 57
- value
- 19.0
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Serum Prostate-specific Antigen Levels
- unit Of Measure
- nanogram per milliliter
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 2.86
- upper Limit
- 5.05
- value
- 3.78
- group Id
- BG001
- lower Limit
- 3.05
- upper Limit
- 5.32
- value
- 4.11
- group Id
- BG002
- lower Limit
- 2.91
- upper Limit
- 5.01
- value
- 3.84
- group Id
- BG003
- lower Limit
- 2.89
- upper Limit
- 5.10
- value
- 3.93
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Serum Testosterone Levels
- unit Of Measure
- nanogram per milliliter
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1109
- value
- 485
- group Id
- BG001
- spread
- 994
- value
- 491
- group Id
- BG002
- spread
- 1088
- value
- 497
- group Id
- BG003
- spread
- 1063
- value
- 491
- description
- ITT population.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time Since Prostate Cancer Diagnosis
- unit Of Measure
- days
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 201
- group Id
- BG003
- value
- 610
- units
- Participants
- groups
- description
- Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 160 mg SC (by injection under the skin) given every 28 days.
- id
- BG000
- title
- Degarelix 240/160 mg
- description
- Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 80 mg SC (by injection under the skin) given every 28 days.
- id
- BG001
- title
- Degarelix 240/80 mg
- description
- Lupron Depot 7.5 mg IM (in the muscle) every 28 days starting at day 0.
- id
- BG002
- title
- Leuprolide 7.5 mg
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 43
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 118
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 165
- group Id
- BG001
- value
- 164
- group Id
- BG002
- value
- 163
- group Id
- BG003
- value
- 492
- title
- >=65 years
- description
- Intent-to-treat (ITT) population.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 50
- spread
- 8.47
- upper Limit
- 88
- value
- 72
- group Id
- BG001
- lower Limit
- 51
- spread
- 8.12
- upper Limit
- 89
- value
- 72
- group Id
- BG002
- lower Limit
- 52
- spread
- 8.77
- upper Limit
- 98
- value
- 74
- group Id
- BG003
- lower Limit
- 50
- spread
- 8.45
- upper Limit
- 98
- value
- 73
- description
- ITT population.
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 202
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 201
- group Id
- BG003
- value
- 610
- title
- Male
- description
- ITT population.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 59
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 2
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 10
- group Id
- BG003
- value
- 38
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 168
- group Id
- BG001
- value
- 171
- group Id
- BG002
- value
- 172
- group Id
- BG003
- value
- 511
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Unknown or Not Reported
- description
- ITT population
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 87
- group Id
- BG002
- value
- 86
- group Id
- BG003
- value
- 257
- title
- North America
- categories
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 120
- group Id
- BG002
- value
- 115
- group Id
- BG003
- value
- 353
- title
- Europe
- description
- ITT population
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 30
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 78
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 178
- group Id
- BG001
- value
- 177
- group Id
- BG002
- value
- 177
- group Id
- BG003
- value
- 532
- title
- No
- description
- ITT population. Curative intent refers to radical prostatectomy or radiotherapy.
- param Type
- NUMBER
- title
- Curative Intent
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 24
- group Id
- BG003
- value
- 65
- title
- 2-4
- categories
- measurements
- group Id
- BG000
- value
- 67
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 198
- title
- 5-6
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 62
- group Id
- BG003
- value
- 181
- title
- 7
- categories
- measurements
- group Id
- BG000
- value
- 56
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 163
- title
- 8-10
- description
- ITT population. The Gleason score is a system of grading the aggressiveness of the prostate cancer and how fast it is likely to grow and spread. Scale is 2-10, with low numbers being the least aggressive and 10 being the most aggressive. Gleason scores were unavailable for 3 patients.
- param Type
- NUMBER
- title
- Gleason Score
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 59
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 63
- group Id
- BG003
- value
- 191
- title
- Localized
- categories
- measurements
- group Id
- BG000
- value
- 62
- group Id
- BG001
- value
- 64
- group Id
- BG002
- value
- 52
- group Id
- BG003
- value
- 178
- title
- Locally advanced
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 47
- group Id
- BG003
- value
- 125
- title
- Metastatic
- categories
- measurements
- group Id
- BG000
- value
- 40
- group Id
- BG001
- value
- 37
- group Id
- BG002
- value
- 39
- group Id
- BG003
- value
- 116
- title
- Not classifiable
- description
- ITT population. Stage of prostate cancer was classified according to the Tumour, Nodule and Metastatic classification that is a cancer staging system that describes the extent of cancer. T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved, and M describes distant metastasis
- param Type
- NUMBER
- title
- Stage of Prostate Cancer
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.70
- value
- 26.6
- group Id
- BG001
- spread
- 4.21
- value
- 26.7
- group Id
- BG002
- spread
- 3.86
- value
- 26.9
- group Id
- BG003
- spread
- 3.93
- value
- 26.8
- description
- ITT population
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Mass Index
- unit Of Measure
- kilogram per square meter
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 8.2
- upper Limit
- 68
- value
- 19.9
- group Id
- BG001
- lower Limit
- 9.4
- upper Limit
- 46
- value
- 19.8
- group Id
- BG002
- lower Limit
- 8.7
- upper Limit
- 57
- value
- 19.0
- group Id
- BG003
- lower Limit
- 8.7
- upper Limit
- 57
- value
- 19.0
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Serum Prostate-specific Antigen Levels
- unit Of Measure
- nanogram per milliliter
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 2.86
- upper Limit
- 5.05
- value
- 3.78
- group Id
- BG001
- lower Limit
- 3.05
- upper Limit
- 5.32
- value
- 4.11
- group Id
- BG002
- lower Limit
- 2.91
- upper Limit
- 5.01
- value
- 3.84
- group Id
- BG003
- lower Limit
- 2.89
- upper Limit
- 5.10
- value
- 3.93
- dispersion Type
- INTER_QUARTILE_RANGE
- param Type
- MEDIAN
- title
- Serum Testosterone Levels
- unit Of Measure
- nanogram per milliliter
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 1109
- value
- 485
- group Id
- BG001
- spread
- 994
- value
- 491
- group Id
- BG002
- spread
- 1088
- value
- 497
- group Id
- BG003
- spread
- 1063
- value
- 491
- description
- ITT population.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time Since Prostate Cancer Diagnosis
- unit Of Measure
- days
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle